Document:

Exhibit
10.1

SECURITIES
PURCHASE AGREEMENT

 

 

THIS
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation
(the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”),
a _______ whose address is _____________.

 

WHEREAS:

 

The
Purchaser desires to shares of common stock in the Company (“Shares”) in accordance with the terms and conditions
set forth herein.

 

The
Company desires to issue and sell Shares to the Purchaser in accordance with the terms and conditions set forth herein.

 

THEREFORE,
IT IS AGREED AS FOLLOWS

 

 

 1. Purchase Price

 

The
purchase price per Share (“Purchase Price”), payable in US Dollars, shall be $1.00 per Share.

 

 

 2. Form of Payment

 

The
Purchaser shall pay the Purchase Price per Share multiplied by that number of Shares Purchased by wire transfer of immediately
available funds to the Company

WIRE
INSTRUCTIONS:

__________________

__________________

 

 3. Issuance of Shares

 

5
business days subsequent to receipt of payment of the Purchase Price the Company shall issue to the Purchaser that number of Shares
purchased

 4. Purchaser’s Representations and Warranties

 

		(a)	As
                                         of the date hereof, the Purchaser is purchasing the Shares for its own account and not
                                         with a present view towards the public sale or distribution thereof, except pursuant
                                         to sales registered or exempted from registration under the Securities Act of 1933, as
                                         amended (the “Act”). 

		(b)	The
                                         Purchaser is an “accredited investor” as that term is defined in Rule 501(a)
                                         of Regulation D promulgated under the Act

		(c)	The
                                         Purchaser and its advisors, if any, have been, furnished with all materials relating
                                         to the business, finances and operations of the Company and materials relating to the
                                         offer and sale of the Shares which have been requested by the Purchaser or its advisors.
                                         Notwithstanding the foregoing, the Company has not disclosed to the Purchaser any material
                                         nonpublic information and will not disclose such information unless such information
                                         is disclosed to the public prior to such disclosure to the Purchaser.

		(d)	Purchaser
                                         has the requisite power and authority to enter into and perform its obligations under
                                         this Agreement without the consent, approval or authorization of, or obligation to notify,
                                         any person, entity or governmental agency which consent has not been obtained.

		(e)	The
                                         execution, delivery and performance of this Agreement by Purchaser does not and shall
                                         not constitute Purchaser’s breach of any statute or regulation or ordinance of
                                         any governmental authority, and shall not conflict with or result in a breach of or default
                                         under any of the terms, conditions, or provisions of any order, writ, injunction, decree,
                                         contract, agreement, or instrument to which the Purchaser is a party, or by which Purchaser
                                         is or may be bound.

 5. Company’s representations and warranties

a)
Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

(b)
The execution, delivery and performance of this Agreement by Company does not and shall not constitute Company’s breach
of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of
or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument
to which the Company is a party, or by which Company is or may be bound.

 6. Restricted Securities Acknowledgement

 

Purchaser
acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act
of 1933 shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Act, and
shall contain the following restrictive legend:

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF
ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.”

8.
Entire Agreement

This
Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter
hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
and representations between the parties.

9.
Governing Law, Venue, Waiver of Jury Trial

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

IN
WITNESS WHEREOF, the parties have hereunto executed this Agreement on the 24th day of October, 2017.

 

Zander
Therapeutics, Inc

/s/David
Koos

David
Koos, CEO

Date:
10/24/2017

 

Purchaser

___________________

By:

Its:

Date:
10/24/2017

Number
of Shares Purchased: 400,000

Total
Purchase Price: $400,000 

 

    	 	1	 

     

    

SECURITIES
PURCHASE AGREEMENT

 

 

THIS
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation
(the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”),
a _______ whose address is _____________.

 

WHEREAS:

 

The
Purchaser desires to shares of common stock in the Company (“Shares”) in accordance with the terms and conditions
set forth herein.

 

The
Company desires to issue and sell Shares to the Purchaser in accordance with the terms and conditions set forth herein.

 

THEREFORE,
IT IS AGREED AS FOLLOWS

 

 

 7. Purchase Price

 

The
purchase price per Share (“Purchase Price”), payable in US Dollars, shall be $1.00 per Share.

 

 8. Form of Payment

 

The
Purchaser shall pay the Purchase Price per Share multiplied by that number of Shares Purchased by wire transfer of immediately
available funds to the Company

WIRE
INSTRUCTIONS:

___________________

___________________

 9. Issuance of Shares

 

5
business days subsequent to receipt of payment of the Purchase Price the Company shall issue to the Purchaser that number of Shares
purchased

 10. Purchaser’s Representations and Warranties

 

		(f)	As
                                         of the date hereof, the Purchaser is purchasing the Shares for its own account and not
                                         with a present view towards the public sale or distribution thereof, except pursuant
                                         to sales registered or exempted from registration under the Securities Act of 1933, as
                                         amended (the “Act”). 

		(g)	The
                                         Purchaser is an “accredited investor” as that term is defined in Rule 501(a)
                                         of Regulation D promulgated under the Act

		(h)	The
                                         Purchaser and its advisors, if any, have been, furnished with all materials relating
                                         to the business, finances and operations of the Company and materials relating to the
                                         offer and sale of the Shares which have been requested by the Purchaser or its advisors.
                                         Notwithstanding the foregoing, the Company has not disclosed to the Purchaser any material
                                         nonpublic information and will not disclose such information unless such information
                                         is disclosed to the public prior to such disclosure to the Purchaser.

		(i)	Purchaser
                                         has the requisite power and authority to enter into and perform its obligations under
                                         this Agreement without the consent, approval or authorization of, or obligation to notify,
                                         any person, entity or governmental agency which consent has not been obtained.

		(j)	The
                                         execution, delivery and performance of this Agreement by Purchaser does not and shall
                                         not constitute Purchaser’s breach of any statute or regulation or ordinance of
                                         any governmental authority, and shall not conflict with or result in a breach of or default
                                         under any of the terms, conditions, or provisions of any order, writ, injunction, decree,
                                         contract, agreement, or instrument to which the Purchaser is a party, or by which Purchaser
                                         is or may be bound.

 11. Company’s representations and warranties

 

a)
Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

(b)
The execution, delivery and performance of this Agreement by Company does not and shall not constitute Company’s breach
of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of
or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument
to which the Company is a party, or by which Company is or may be bound.

 12. Restricted Securities Acknowledgement

 

Purchaser
acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act
of 1933 shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Act, and
shall contain the following restrictive legend:

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF
ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.”

8.
Entire Agreement

This
Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter
hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
and representations between the parties.

9.
Governing Law, Venue, Waiver of Jury Trial

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

IN
WITNESS WHEREOF, the parties have hereunto executed this Agreement on the 24th day of October, 2017.

 

Zander
Therapeutics, Inc

/s/David
Koos

David
Koos, CEO

Date:
10/24/2017

 

Purchaser

___________________

By:

Its:

Date:
10/24/2017

Number
of Shares Purchased: 200,000

Total
Purchase Price: $200,000

    	 	2	 

     

    

 

SECURITIES
PURCHASE AGREEMENT

 

 

THIS
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation
(the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”),
a _______ whose address is _____________.

 

WHEREAS:

 

The
Purchaser desires to shares of common stock in the Company (“Shares”) in accordance with the terms and conditions
set forth herein.

 

The
Company desires to issue and sell Shares to the Purchaser in accordance with the terms and conditions set forth herein.

 

THEREFORE,
IT IS AGREED AS FOLLOWS

 

 

 13. Purchase Price

 

The
purchase price per Share (“Purchase Price”), payable in US Dollars, shall be $1.00 per Share.

 

 14. Form of Payment

 

The
Purchaser shall pay the Purchase Price per Share multiplied by that number of Shares Purchased by wire transfer of immediately
available funds to the Company

WIRE
INSTRUCTIONS:

__________________

___________________

 15. Issuance of Shares

 

5
business days subsequent to receipt of payment of the Purchase Price the Company shall issue to the Purchaser that number of Shares
purchased

 16. Purchaser’s Representations and Warranties

 

		(k)	As
                                         of the date hereof, the Purchaser is purchasing the Shares for its own account and not
                                         with a present view towards the public sale or distribution thereof, except pursuant
                                         to sales registered or exempted from registration under the Securities Act of 1933, as
                                         amended (the “Act”). 

		(l)	The
                                         Purchaser is an “accredited investor” as that term is defined in Rule 501(a)
                                         of Regulation D promulgated under the Act

		(m)	The
                                         Purchaser and its advisors, if any, have been, furnished with all materials relating
                                         to the business, finances and operations of the Company and materials relating to the
                                         offer and sale of the Shares which have been requested by the Purchaser or its advisors.
                                         Notwithstanding the foregoing, the Company has not disclosed to the Purchaser any material
                                         nonpublic information and will not disclose such information unless such information
                                         is disclosed to the public prior to such disclosure to the Purchaser.

		(n)	Purchaser
                                         has the requisite power and authority to enter into and perform its obligations under
                                         this Agreement without the consent, approval or authorization of, or obligation to notify,
                                         any person, entity or governmental agency which consent has not been obtained.

		(o)	The
                                         execution, delivery and performance of this Agreement by Purchaser does not and shall
                                         not constitute Purchaser’s breach of any statute or regulation or ordinance of
                                         any governmental authority, and shall not conflict with or result in a breach of or default
                                         under any of the terms, conditions, or provisions of any order, writ, injunction, decree,
                                         contract, agreement, or instrument to which the Purchaser is a party, or by which Purchaser
                                         is or may be bound.

 17. Company’s representations and warranties

 

a)
Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

(b)
The execution, delivery and performance of this Agreement by Company does not and shall not constitute Company’s breach
of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of
or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument
to which the Company is a party, or by which Company is or may be bound.

 18. Restricted Securities Acknowledgement

 

Purchaser
acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act
of 1933 shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Act, and
shall contain the following restrictive legend:

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF
ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.”

8.
Entire Agreement

This
Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter
hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
and representations between the parties.

9.
Governing Law, Venue, Waiver of Jury Trial

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

 

IN
WITNESS WHEREOF, the parties have hereunto executed this Agreement on the 24th day of October, 2017.

 

Zander
Therapeutics, Inc

/s/David
Koos

David
Koos, CEO

Date:
10/24/2017

 

Purchaser

___________________

By:

Its:

Date:
10/24/2017

Number
of Shares Purchased: 300,000

Total
Purchase Price: $300,000Exhibit
10.2

 

AMENDMENT
NO. 2 TO THE 

WASTE
CONNECTIONS, INC.

NONQUALIFIED
DEFERRED COMPENSATION PLAN

 

WHEREAS,
Waste Connection Inc., an Ontario corporation (the “Employer”), has previously established the Waste Connections, Inc.
Nonqualified Deferred Compensation Plan (the “Plan”) for the benefit of a select group of management or highly compensated
employees and directors; and

 

WHEREAS,
the Employer most recently amended the Plan effective July 19, 2016; and

 

WHEREAS,
the Employer had previously allowed participants to defer restricted stock unit awards under the Plan, but disallowed such deferrals
beginning in the 2015 Plan year; and

 

WHEREAS,
the Employer desires to allow participants who previously deferred restricted stock unit awards under the Plan’s terms to
elect to exchange the portion of their Account Balance credited to the Stock Equivalent Account for one or more of the Measurement
Funds;

 

NOW,
THEREFORE, pursuant to Section 11.2 of the Plan, the following amendment is hereby made, and shall be effective on the date
executed below.

 

I.           Section
3.9(a) of the Plan is hereby amended by revising the final sentence thereof to be and read as follows:

 

“Except
as otherwise provided in Section 9(g) below, the portion of the Annual Deferral Amount deferred with respect to Restricted Stock
Unit Awards shall only be deemed invested in the Company’s Common Stock and such deferrals shall be recorded in the Stock
Equivalent Account.”

 

II.          Section
3.9(b) of the Plan is hereby amended by revising the final sentence thereof to be and read as follows:

 

“Notwithstanding
any of the foregoing, amounts credited or debited to a Participant’s Account Balance with respect to Restricted Stock Unit
Awards, if applicable, shall, except as otherwise provided in Section 9(g) below, only be deemed invested in the Company’s
Common Stock and such deferrals shall be recorded in the Stock Equivalent Account.”

 

III.          Section
3.9(c) of the Plan is hereby amended by revising the final sentence thereof to be and read as follows:

 

“Notwithstanding
the foregoing, except as otherwise provided in Section 9(g) below, one hundred percent (100%) of the amounts credited or debited
to a Participant’s Account Balance with respect to Restricted Stock Unit Awards, if applicable, shall be recorded in the
Participant’s Stock Equivalent Account.”

 

    	 	1	 

     

    

 

IV.          Section
3.9 of the Plan is hereby amended by adding the following new Section 3.9(g) to the end thereof, to be and read as follows:

 

“(g)         A
Participant who has attained age fifty-five (55) and has a portion of the Participant’s Account Balance credited to the Stock
Equivalent Account may elect to cause some or all of the Qualifying Stock Units (as defined below) credited to the Stock Equivalent
Account to instead be credited to one or more of the Measurement Funds then available under the Plan’s terms. An election
under the preceding sentence shall be submitted to the Committee during any period in which the Company has an open trading window
under the Company’s insider trading policy, as determined by the Company’s General Counsel, and such change in investment
allocation shall occur during such open trading window. Any election made under this Section 3.9(g) shall designate the number
of Qualifying Stock Units that will no longer be deemed to be invested in the Stock Equivalent Account and, as soon as administrative
feasible thereafter, the value of such Qualifying Stock Units shall be reinvested in one or more Measurement Funds.

 

For
purposes of this Section 3.9(g), a “Qualifying Stock Unit” shall be an amount which:

 

		(i)	is deemed to be invested in a share of the Company’s Common Stock as a result of a deferral
election filed by the Participant with respect to a Restricted Stock Unit Award;

		(ii)	is scheduled to be distributed pursuant to a multi-year Annual Installment Method election following
the Participant’s Separation from Service; and

		(iii)	has been vested for at least three (3) years prior to the date such transfer election is made.
Notwithstanding any provision of this Plan to the contrary, a Participant may not elect to have any amount previously credited
to a Measurement Fund instead credited to the Stock Equivalent Account.”

 

IN
WITNESS WHEREOF, the Employer has caused this instrument to be executed this 25th day of October, 2017.

 

	 	WASTE CONNECTIONS, INC.
	 	 
	 	By:	/s/ Ronald J. Mittelstaedt
	 	 	 
	 	Its:	Chief Executive Officer

 

    	 	2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]